原發(fā)性肝癌病人的護(hù)理詳解醫(yī)學(xué)幻燈片_第1頁
原發(fā)性肝癌病人的護(hù)理詳解醫(yī)學(xué)幻燈片_第2頁
原發(fā)性肝癌病人的護(hù)理詳解醫(yī)學(xué)幻燈片_第3頁
原發(fā)性肝癌病人的護(hù)理詳解醫(yī)學(xué)幻燈片_第4頁
原發(fā)性肝癌病人的護(hù)理詳解醫(yī)學(xué)幻燈片_第5頁
已閱讀5頁,還剩14頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

轉(zhuǎn)移背闊肌肌皮瓣修復(fù)術(shù)在局部晚期乳腺癌手術(shù)中的應(yīng)用,.,Contents,局部晚期乳腺癌定義,局部晚期乳腺癌治療現(xiàn)狀,背闊肌解剖學(xué),背闊肌肌皮瓣修復(fù)術(shù)手術(shù)要點(diǎn),注意事項(xiàng)及臨床體會(huì),.,局部晚期乳腺癌治療現(xiàn)狀?,.,Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.,METHODS: We reviewed clinicopathological data on patients who received NCT for stage I-III breast cancer from 1994 to 2007. Chemotherapy regimens were anthracycline-and/or taxane-based as determined by the treating medical oncologist. RESULTS: Of 1,928 patients who received NCT, 1,762 (91%) had a partial or complete response, 107 (6%) had stable disease (SD), and 59 (3%) progressed (PD) while receiving at least one regimen. Of the patients with progressive disease, 40 (68%) patients underwent mastectomy, 12 (20%) underwent BCT, and 7 (12%) did not undergo surgery. In patients who underwent mastectomy, only three (8%) were BCT candidates before progression. Overall, disease progression changed the operative plan in 11 (0.5%) patients: 3 developed distant metastasis, 2 developed clinical lymphadenopathy, 3 required mastectomy instead of BCT, 2 became inoperable, and 1 required flap closure.CONCLUSIONS: Disease progression while receiving NCT is infrequent (3%), but early identification may allow for change to other, potentially beneficial, therapeutic interventions. Patients with breast cancer who receive NCT should be evaluated frequently for response to therapy. Overall, progression during NCT changes the surgical management in a small proportion of patients.,Caudle AS et al. Ann Surg Oncol. 2011 Apr;18(4):932-8.,.,轉(zhuǎn)移背闊肌肌皮瓣修復(fù)術(shù)適應(yīng)癥及禁忌癥,適應(yīng)癥:乳房切除術(shù)后皮膚缺損乳腺癌根治術(shù)后自體組織乳房重建保乳術(shù)后局部畸形放療后胸壁潰瘍,禁忌癥開胸術(shù)后背闊肌被切斷胸背血管受損者上胸壁大面積皮膚缺損者,.,背闊肌的解剖學(xué)基礎(chǔ),.,背闊肌解剖學(xué),位于肩胛骨下方,三角形發(fā)于T7T12、腰骶椎和最下面34根肋骨,止于肱骨結(jié)節(jié)間溝供血來源于胸背動(dòng)脈和內(nèi)乳動(dòng)脈及肋間動(dòng)脈的穿支神經(jīng)支配為胸背神經(jīng)功能:使肱骨內(nèi)旋,上臂的內(nèi)收和外展,.,背闊肌肌皮瓣的應(yīng)用,歷史:Baudet (1976) 首先進(jìn)行了游離移植的報(bào)道。以后臨床廣泛應(yīng)用,成為最常用的游離皮瓣之一 皮瓣特點(diǎn):血管分布恒定,蒂部管徑在1.52.0mm。血管蒂長:68cm易于剝離和切取供區(qū)范圍大:68cmX 1215cm供區(qū)不遺留明顯的功能障礙皮瓣血運(yùn)豐富可形成單純的肌瓣可用于進(jìn)行肌肉功能的重建 應(yīng)用范圍:帶蒂移植:胸部、上肢的組織缺損,屈肘功能重建,乳房再造等游離移植:頭、面、頸、四肢、軀干等部位均可應(yīng)用,.,1,術(shù)前先描畫出手術(shù)切口全麻下,先仰臥位,行乳腺癌改良根治或根治術(shù)乳房切口徹底止血后用濕大紗布覆蓋并用無菌手術(shù)膜隔離,.,2,再取側(cè)臥位,在背闊肌表面按預(yù)先設(shè)計(jì)的梭形切口逐層切開沿背闊肌前緣切取背闊肌并向后方延續(xù),注意保護(hù)前鋸肌及大圓肌注意保護(hù)血管蒂把肌皮瓣經(jīng)皮下隧道輕送到乳房創(chuàng)面,.,3,再改為仰臥位,將轉(zhuǎn)移的肌皮瓣縫合固定于前胸壁切口并關(guān)閉皮膚切口切口輕度加壓包扎引流管負(fù)壓吸引,.,手術(shù)技巧及注意事項(xiàng),.,1.體位,1.先仰臥位;2.側(cè)臥位;3.最后仰臥位,.,2.保護(hù)胸背血管蒂,胸背血管,胸外側(cè)血管,.,5.慎防誤切大圓肌及前鋸肌,誤切上述二肌肉會(huì)引起肩關(guān)節(jié)內(nèi)收功能障礙,.,臨床體會(huì),.,

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論